| Bal Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524824 |
NSE Symbol : BALPHARMA |
P/E(TTM) : 15.48 |
|
ISIN Demat : INE083D01012 |
Div & Yield% : 1.67 |
EPS(TTM) : 4.65 |
|
Book Value(₹) : 62.77 |
Market Cap(₹Cr) : 114.63 |
Face Value(₹) : 10.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 73.75 | 65.64 | 81.78 | 72.89 | 74.70 | 73.13 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 73.75 | 65.64 | 81.78 | 72.89 | 74.70 | 73.13 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.13 | 0.74 | 0.99 | 0.51 | 0.35 | 0.29 |
| Total Income | 74.88 | 66.38 | 82.77 | 73.39 | 75.05 | 73.41 |
| Total Expenditure | 67.98 | 59.48 | 73.95 | 64.95 | 67.22 | 66.56 |
| PBIDT | 6.91 | 6.89 | 8.82 | 8.45 | 7.82 | 6.85 |
| Interest | 3.86 | 4.05 | 3.94 | 5.02 | 4.18 | 3.71 |
| PBDT | 3.05 | 2.84 | 4.88 | 3.42 | 3.64 | 3.14 |
| Depreciation | 2.27 | 2.52 | 2.07 | 2.68 | 2.12 | 2.43 |
| Tax | 0.00 | 0.00 | -1.30 | 0.14 | 0.47 | 0.55 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | -1.49 | -0.10 | -0.15 | -0.19 |
| Reported Profit After Tax | 0.78 | 0.32 | 5.61 | 0.69 | 1.20 | 0.36 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 0.78 | 0.32 | 5.61 | 0.69 | 1.20 | 0.36 |
| EPS (Unit Curr.) | 0.49 | 0.20 | 3.51 | 0.73 | 0.76 | 0.23 |
| EPS (Adj) (Unit Curr.) | 0.49 | 0.20 | 3.51 | 0.73 | 0.76 | 0.23 |
| Calculated EPS (Unit Curr.) | 0.49 | 0.20 | 3.52 | 0.43 | 0.76 | 0.23 |
| Calculated EPS (Adj) (Unit Curr.) | 0.49 | 0.20 | 3.52 | 0.43 | 0.76 | 0.23 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.96 | 0.81 | 14.09 | 1.74 | 3.02 | 0.91 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.96 | 0.81 | 14.09 | 1.74 | 3.02 | 0.91 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 15.92 | 15.92 | 15.92 | 15.92 | 15.92 | 15.80 |
| Reserve & Surplus | 0.00 | 0.00 | 82.90 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 9.37 | 10.50 | 10.79 | 11.59 | 10.47 | 9.37 |
| PBDTM(%) | 4.14 | 4.33 | 5.97 | 4.69 | 4.87 | 4.29 |
| PATM(%) | 1.06 | 0.49 | 6.86 | 0.95 | 1.61 | 0.49 |